Successful Maintenance Belatacept-Based Immunosuppression in Lung Transplantation Recipients Who Failed Calcineurin Inhibitors

被引:0
|
作者
Ensor, C. [1 ]
Winstead, R. [1 ]
Johnson, B. [1 ]
Morrell, M. [1 ]
Kilaru, S. [1 ]
Moore, C. [1 ]
Hayanga, J. [1 ]
Zeevi, A. [1 ]
Lendermon, E. [1 ]
McDyer, J. [1 ]
机构
[1] Univ Pittsburgh, Pittsburgh, PA USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
152
引用
收藏
页码:257 / 257
页数:1
相关论文
共 50 条
  • [41] Use of Basiliximab in Recipients Who Required Dose Reduction or Discontinuation of Calcineurin Inhibitors Early After Lung Transplantation
    Morimura, Y.
    Tanaka, S.
    Kayawake, H.
    Yamada, Y.
    Yutaka, Y.
    Ohsumi, A.
    Nakajima, D.
    Hamaji, M.
    Date, H.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S529 - S529
  • [42] Belatacept-Based Immunosuppression in De Novo Liver Transplant Recipients: 1-Year Experience from a Phase II Study
    Garcia-Valdecasas, J. C.
    Feng, S.
    Lake, J. R.
    Vargas, H. E.
    Wekerle, T.
    Meadows-Shropshire, S.
    Agarwal, M.
    Klintmalm, G. B.
    LIVER TRANSPLANTATION, 2011, 17 (06) : S79 - S79
  • [43] Belatacept-Based Immunosuppression in De Novo Liver Transplant Recipients: 1-Year Experience from a Phase II Study
    Klintmalm, G. B.
    Feng, S.
    Lake, J. R.
    Vargas, H. E.
    Wekerle, T.
    Meadows-Shropshire, S.
    Agarwal, M.
    Garcia-Valdecasas, J. C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 137 - 137
  • [44] EVEROLIMUS (EVE) IN MAINTENANCE RENAL TRANSPLANT RECIPIENTS CONVERTED FROM CALCINEURIN INHIBITORS (CNI) IMMUNOSUPPRESSION TREATMENT
    Rengel, Manuel
    Abad, Soraya
    Vega, Almudena
    Verdalles, Ursula
    Verde, Eduardo
    TRANSPLANT INTERNATIONAL, 2011, 24 : 39 - 40
  • [45] Belatacept-Based Immunosuppression in De Novo Liver Transplant Recipients: 1-Year Experience From a Phase II Randomized Study
    Klintmalm, G. B.
    Feng, S.
    Lake, J. R.
    Vargas, H. E.
    Wekerle, T.
    Agnes, S.
    Brown, K. A.
    Nashan, B.
    Rostaing, L.
    Meadows-Shropshire, S.
    Agarwal, M.
    Harler, M. B.
    Garcia-Valdecasas, J. -C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 (08) : 1817 - 1827
  • [46] Belatacept-Based Maintenance Immunosuppression Promoted Long-Term Antibody-Mediated Rejection Free Graft Survival After Desensitization in Sensitized Multiparous Female Recipients.
    Manook, M.
    Anwar, I.
    Schmitz, R.
    Fitch, Z.
    Yoon, J.
    Jackson, A.
    Kwun, J.
    Knechtle, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 409 - 409
  • [47] Early conversion to belatacept-based immunosuppression regimen promotes improved long-term renal graft function in kidney transplant recipients
    Moein, Mahmoudreza
    Dvorai, Reut Hod
    Li, Benson W.
    Fioramonti, P. J.
    Schilsky, Juliana B.
    Thankachan, Reeba
    Yang, Christine
    Saidi, Reza F.
    Shahbazov, Rauf
    TRANSPLANT IMMUNOLOGY, 2023, 80
  • [48] IMMUNOSUPPRESSION WITH BELATACEPT-BASED, CNI-FREE, STEROID-AVOIDING REGIMENS IN KIDNEY TRANSPLANT RECIPIENTS: 6 MONTH, INTERIM RESULTS
    Grinyo, J. M.
    Marks, W.
    Vincenti, F.
    Kaufman, D.
    Marder, B.
    Woodle, S.
    Citterio, F.
    Agarwal, M.
    Garg, P.
    Lin, C. -S.
    Ferguson, R.
    TRANSPLANT INTERNATIONAL, 2009, 22 : 90 - 91
  • [50] Einsatz von Belatacept nach Nierentransplantation ohne Erhaltungstherapie mit Steroiden oder CalcineurininhibitorenRenal transplantation using belatacept without maintenance steroids or calcineurin inhibitors
    J. Beimler
    Der Nephrologe, 2015, 10 (1): : 49 - 50